Hepatitis C in North Africa: A Comprehensive Review of Epidemiology, Genotypic Diversity, and Hepatocellular Carcinoma
Advances in Virology · 2025-01 · 2025 (1)
DOI: 10.1155/av/9927410 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Virology, online erschienen am 24.03.2025. Verfasst von Samia Boukaira und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Institut Pasteur du Maroc, Casablanca, Morocco. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation OCP.
Abstract (Originalsprache)
Hepatitis C virus (HCV) is implicated in carcinogenic infections like hepatocellular carcinoma (HCC). Given that no HCV vaccine is currently available, comprehensive epidemiological understanding is crucial for devising effective prevention strategies. In North Africa, existing data on HCV infection and HCV‐associated HCC are frequently outdated or limited to specific populations. This systematic review aims to offer new insights into the epidemiology of HCV infection, HCV genotype distribution, and HCV‐related HCC in this region. We collected data from electronic databases: PubMed, ScienceDirect, ResearchGate, Google Scholar, and public health reports between 1989 and 2023. We reported the studies carried out in each country in general populations and in groups exposed to HCV infection. Our results show that HCV prevalence varies from 0.5% to 4.61% among the general populations in North African countries. HCV genotype 1 remains the most dominant in the Greater Maghreb region, while genotype 4 is the most dominant in the Nile Valley region. HCC incidence varies between the five countries, and HCV is responsible for 60% of cases, with male dominance. Egypt had the highest number of deaths from HCV‐associated HCC. Other factors such as HBV, diabetes, and alcohol use are also responsible for HCC in North Africa. Urban growth and socioeconomic changes have impacted HCV prevalence in the North African region, especially among rural populations, and introduced new risks, such as coinfections and Type 2 diabetes. Here, we propose some recommendations for HCV control and management by patient category in North Africa.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biology, Institut Pasteur du Maroc, Casablanca, Morocco.
- Department of Microbiology and Molecular Biology, Faculté des Sciences, Université Mohammed V de Rabat, Rabat, Morocco.
- Department of Human Genomics and Genetics, Institut Pasteur du Maroc, Casablanca, Morocco.
- Department of Biological Sciences, Faculty of Medical Sciences, Université Mohammed VI Polytechnique EMINES, Benguerir, Morocco.
ORCID-Profile: Samia Boukaira, Salma Madihi, Bouchra Belkadi, Abdelouaheb Benani
Förderung
- Fondation OCP
Zitieren
APA
Boukaira, S., Madihi, S., Bouafi, H., Rchiad, Z., Belkadi, B., & Benani, A. (2025). Hepatitis C in North Africa: A Comprehensive Review of Epidemiology, Genotypic Diversity, and Hepatocellular Carcinoma. Advances in Virology, 2025(1). https://doi.org/10.1155/av/9927410
Vancouver
Boukaira S, Madihi S, Bouafi H, Rchiad Z, Belkadi B, Benani A. Hepatitis C in North Africa: A Comprehensive Review of Epidemiology, Genotypic Diversity, and Hepatocellular Carcinoma. Advances in Virology. 2025;2025(1). doi:10.1155/av/9927410
BibTeX
@article{Boukaira2025,
author = {Boukaira, Samia and Madihi, Salma and Bouafi, Hind and Rchiad, Zineb and Belkadi, Bouchra and Benani, Abdelouaheb},
title = {Hepatitis C in North Africa: A Comprehensive Review of Epidemiology, Genotypic Diversity, and Hepatocellular Carcinoma},
journal = {Advances in Virology},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/av/9927410}
}
EUVIMED